ST. LOUIS, May 10, 2012 /PRNewswire/ -- Challenged by weak demand in its domestic markets, Allied Healthcare Products Inc. (NASDAQ: AHPI) reported a loss for the third quarter of fiscal year 2012 on a decline in sales.

Net income for the quarter ending March 31 was a negative $146,000, or negative 2 cents per basic and diluted share, versus net income of $60,000, or 1 cent per share, for the prior year. Sales for the quarter declined from about $11.3 million to $10.7 million, or about 5.3 percent, from the previous year.

For the first three quarters of the 2012 fiscal year, net income fell from almost $90,000, or 1 cent per basic and diluted share, to a negative $268,000, or a negative 3 cents per share. Sales for the first three quarters declined from about $34.7 million to $32.8 million, or about 5.5 percent, compared to the previous year.

The bright spot in the sales picture was international sales which increased about 12.9 percent over the previous year's quarter and by about 6.4 percent for the first three quarters.

Commodity prices increased about 12.4 percent over the previous year. However, cost reduction projects in manufacturing offset increased material costs.

Allied will introduce cartridges that will facilitate use of its CO2 absorbent Litholyme® product in the fourth quarter of 2012, said Earl Refsland, Allied Healthcare Products president and chief executive officer.

Allied Healthcare Products manufactures a variety of respiratory products used in the healthcare industry in a range of hospital and alternate care settings including sub-acute facilities, home healthcare and emergency medical care. Allied product lines include respiratory care products, medical gas equipment and emergency medical products. Allied products are marketed to hospitals, hospital equipment dealers, hospital construction contractors, home healthcare dealers and emergency medical product dealers.

"SAFE HARBOR" STATEMENT: Statements contained in this release that are not historical facts or information are "forward-looking statements."  Words such as "believe," "expect," "intend," "will," "should," and other expressions that indicate future events and trends identify such forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome and future results of operations and financial condition to be materially different than stated or anticipated based on the forward-looking statements. Such risks and uncertainties include both general economic risks and uncertainties, risks and uncertainties affecting the demand for and economic factors affecting the delivery of health care services, and specific matters which relate directly to the Company's operations and properties as discussed in its periodic filings with the Securities and Exchange Commission. The Company cautions that any forward-looking statement contained in this report reflects only the belief of the Company or its management at the time the statement was made. Although the Company believes such forward-looking statements are based upon reasonable assumptions, such assumptions may ultimately prove inaccurate or incomplete. The Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement was made.



ALLIED HEALTHCARE PRODUCTS, INC.



CONSOLIDATED STATEMENT OF OPERATIONS



(UNAUDITED)



















Three months ended,



Nine months ended,



March 31,



March 31,



2012



2011



2012



2011

















Net sales

$10,702,421



$11,338,196



$32,778,824



$34,681,610

Cost of sales

8,377,307



8,729,823



25,312,756



26,712,541

Gross profit

2,325,114



2,608,373



7,466,068



7,969,069

































Selling General and administrative expenses

2,555,649



2,494,806



7,883,631



7,780,116

Income (loss) from operations

(230,535)



113,567



(417,563)



188,953

































Interest income

(5,692)



(8,150)



(21,984)



(23,692)

Interest expense

-



-



336



66

Other, net

10,297



24,421



36,446



67,931



4,605



16,271



14,798



44,305

















Income (loss) before provision for















(benefit from) income taxes

(235,140)



97,296



(432,361)



144,648

















Provision for (benefit from) income taxes

(89,353)



36,972



(164,297)



54,966

Net income (loss)

($145,787)



$60,324



($268,064)



$89,682

















Net income (loss) per share - Basic 

($0.02)



$0.01



($0.03)



$0.01

















Net income (loss) per share - Diluted

($0.02)



$0.01



($0.03)



$0.01

















Weighted average common shares outstanding - Basic

8,124,386



8,113,434



8,124,386



8,101,643

















Weighted average common shares outstanding - Diluted

8,124,386



8,195,174



8,124,386



8,121,042























ALLIED HEALTHCARE PRODUCTS, INC.



CONSOLIDATED BALANCE SHEET



(UNAUDITED)















March 31, 2012



June 30, 2011

ASSETS







Current assets:









Cash and cash equivalents

$           6,375,285



$         6,512,887



Accounts receivable, net of allowances









  of $300,000

4,123,940



5,366,860



Inventories, net

10,338,003



10,553,289



Income tax receivable

-



95,578



Other current assets

665,404



213,745



    Total current assets

21,502,632



22,742,359



Property, plant and equipment, net

9,307,647



8,660,507



Other assets, net

562,112



362,480



    Total assets

$         31,372,391



$       31,765,346











LIABILITIES AND STOCKHOLDERS' EQUITY







Current liabilities:









Accounts payable

$           1,588,091



$         1,644,910



Other accrued liabilities

2,073,899



1,645,552



Deferred income taxes

499,417



512,572



Deferred revenue

286,750



688,200



    Total current liabilities

4,448,157



4,491,234











Deferred revenue

-



114,700











Commitments and contingencies

















Stockholders' equity:









Preferred stock; $0.01 par value; 1,500,000 shares

-



-



  authorized; no shares issued and outstanding









Series A preferred stock; $0.01 par value; 200,000 shares

-



-



  authorized; no shares issued and outstanding









Common stock; $0.01 par value; 30,000,000 shares









  authorized; 10,427,878 shares issued at March 31, 









  2012 and June 30, 2011; 8,124,386 shares outstanding









  at March 31, 2012 and June 30, 2011

104,279



104,279



Additional paid-in capital

48,531,989



48,499,103



Accumulated deficit

(980,606)



(712,542)



Less treasury stock, at cost; 2,303,492 shares at









   March 31, 2012 and June 30, 2011

(20,731,428)



(20,731,428)



    Total stockholders' equity

26,924,234



27,159,412



    Total liabilities and stockholders' equity

$         31,372,391



$       31,765,346

SOURCE Allied Healthcare Products, Inc.

Copyright 2012 PR Newswire

Allied Healthcare Products (NASDAQ:AHPI)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Allied Healthcare Products.
Allied Healthcare Products (NASDAQ:AHPI)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Allied Healthcare Products.